Dr. Reddy's Laboratories Aktie

Dr. Reddy's Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 659157 / ISIN: US2561352038

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
28.10.2020 11:41:17

Dr. Reddy's Labs Names Parag Agarwal CFO Succeeding Saumen Chakraborty

(RTTNews) - Dr. Reddy's Laboratories Ltd. (DRREDDY, RDY) announced Wednesday the appointment of Parag Agarwal as Chief Financial Officer, succeeding Saumen Chakraborty.

Agarwal will join the company as Chief Financial Officer Designate on November 2, and will be Chief Financial Officer (KMP) effective December 1.

Chakraborty, currently President & CFO, will retire effective December 1 after 19+ years at Dr. Eddy's. He will continue to be associated with the Company as an Advisor and also help Agarwal to transition effectively.

Agarwal joins Dr. Reddy's from Reckitt Benckiser PLC, where he was CFO-Health, based in London. Prior to his nine years stint at Reckitt, he was associated with organizations such as Unilever, GSK Consumer Healthcare & Genpact.

Analysen zu Dr. Reddy's Laboratories Ltd. (Spons. ADRS)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel